Well I now own CYP shares once agan. A simple amount in CYP for my portfolio, greater than most perhaps, but not of Sector's standards.
My usual strategy is in place, to buy more....if the price decreases, at increasing volumes to a set limit that I am prepared to lose.
With this stock, and how it trades so poorly in volume, my buy awaiting should prove to be a buffer.against it going lower than the current low.
What the FDA does, re the latest MSB submission ( due on or before August 2 ) , will determine the future of all stem cell based Companies.
I
Ann: Two-Year Results of Phase 1 SR-aGvHD Trial Presented at ISCT, page-21
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
16.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $36.15M | |||
| Open | High | Low | Value | Volume |
| 16.0¢ | 16.5¢ | 16.0¢ | $62.06K | 386.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 5000 | 16.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 17.0¢ | 70000 | 2 |
View Market Depth
| Last trade - 14.47pm 25/06/2025 (20 minute delay) ? |
| CYP (ASX) Chart |